These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34045359)

  • 1. Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.
    Sivakumaran J; Harvey P; Omar A; Tayer-Shifman O; Urowitz MB; Gladman DD; Anderson N; Su J; Touma Z
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 34045359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.
    Choi MY; Guan H; Yoshida K; Paudel M; Kargere BA; Li D; Ellrodt J; Stevens E; Cai T; Weber BN; Everett BM; Costenbader KH
    Semin Arthritis Rheum; 2024 Aug; 67():152468. PubMed ID: 38788567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
    Panopoulos S; Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Lupus Sci Med; 2023 Mar; 10(1):. PubMed ID: 36868585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
    Urowitz MB; Ibañez D; Su J; Gladman DD
    J Rheumatol; 2016 May; 43(5):875-9. PubMed ID: 26879352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
    Zhu L; Singh M; Lele S; Sahakian L; Grossman J; Hahn B; McMahon M
    Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus.
    Mu X; Wu A; Hu H; Zhou H; Yang M
    Front Endocrinol (Lausanne); 2022; 13():1077632. PubMed ID: 36518244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus.
    Edwards N; Langford-Smith AWW; Parker BJ; Bruce IN; Reynolds JA; Alexander MY; McCarthy EM; Wilkinson FL
    Lupus Sci Med; 2018; 5(1):e000272. PubMed ID: 30167314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2020 Mar; ():2047487320906650. PubMed ID: 32122200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
    Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
    Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head.
    Barinotti A; Radin M; Cecchi I; Foddai SG; Arbrile M; Rubini E; Menegatti E; Roccatello D; Sciascia S
    Int J Cardiol; 2022 Sep; 363():185-189. PubMed ID: 35714714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease.
    Hammam N; Abdel-Wahab N; Gheita TA
    Curr Rheumatol Rev; 2021; 17(1):122-130. PubMed ID: 33030132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.
    Vázquez-Del Mercado M; Perez-Vazquez FJ; Gomez-Bañuelos E; Chavarria-Avila E; Llamas-García A; Arrona-Rios KI; Diaz-Rubio GI; Durán-Barragán S; Navarro-Hernández RE; Jordán-Estrada BP; Prado-Bachega N; Gonzalez-Beltran MAA; Ramos-Becerra C; Grover-Paez F; Cardona-Müller D; Cardona-Muñoz EG
    PLoS One; 2018; 13(12):e0207520. PubMed ID: 30517121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
    Di Battista M; Tani C; Elefante E; Chimera D; Carli L; Ferro F; Stagnaro C; Mosca M
    Clin Exp Rheumatol; 2020; 38(4):602-608. PubMed ID: 31694741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
    Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
    Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
    Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
    Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pulse-mass index as a predictor of cardiovascular events in women with systemic lupus erythematosus.
    García-Villegas EA; Márquez-González H; Flores-Suárez LF; Villa-Romero AR
    Med Clin (Barc); 2017 Jan; 148(2):57-62. PubMed ID: 27865435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic syndrome for the development of cardiovascular disease in a cohort of premenopausal women with systemic lupus erythematosus.
    García-Villegas EA; Lerman-Garber I; Flores-Suárez LF; Aguilar-Salinas C; Márquez González H; Villa-Romero AR
    Med Clin (Barc); 2015 Apr; 144(7):289-96. PubMed ID: 25458513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.